VCAM1 and chronic kidney disease: Within a longitudinal study we for the first time show that inflammation as measured by IL-6 and a biomarkers-based inflammation score and endothelial dysfunction as measured by VCAM-1, is associated with LVMI worsening over time in patients across the whole spectrum of pre-dialysis CKD.